Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Initiation Research Published by Pello Capital

19 Sep 2019 07:00

RNS Number : 8814M
Adamas Finance Asia Limited
19 September 2019
 

RNS REACH

19 September 2019

ADAMAS FINANCE ASIA LIMITED

(the "Company" or "ADAM")

Initiation Research published by Pello Capital

Adamas Finance Asia Limited (AIM: ADAM), the London quoted pan-Asian diversified investment vehicle, is pleased to announce that Pello Capital Limited, the Company's Joint Corporate Broker, has this morning initiated research on ADAM (the "Note").

 

The Note provides a comprehensive introduction to the Company, its focus on investing in pan-Asian small and medium-sized enterprises, its portfolio investments, the Company's commitment to its strategy of providing investors with capital growth and dividend income and the potential opportunities present in ADAM's investable universe.

 

The Note is available to download by visiting the following link:

http://adamasfinance.com/assets/research/pello-capital-initiation-note.pdf

 

For further information, please visit the Company's website at http://adamasfinance.com and follow the Company on Twitter (@AdamasFinance).

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Adamas Finance Asia Limited

+44 (0) 1825 830587

John Croft

 

WH Ireland Limited - Nominated Adviser

 

+44 (0) 20 7220 1666

James Joyce

James Sinclair Ford

VSA Capital Limited - Joint Corporate Broker 

+44 (0) 20 3005 5000

Andrew Monk

Andrew Raca

Pello Capital Limited - Joint Corporate Broker

+44 (0) 20 3700 2500

Tim Sohal

Maitland/AMO - Communications Advisor

+44 (0) 20 7379 5151

James Benjamin

Peter Hamid

 

About Adamas Finance Asia

ADAM is a London quoted investment company focusing on delivering long-term income and capital growth to shareholders through a diverse portfolio of pan-Asian investments. It is committed to providing for investors attractive uncorrelated returns through a combination of capital growth and dividend income well diversified by national geographies and asset classes from the Asian Small and Medium Enterprise (SME) sector.

 

The Company's investment manager, Harmony Capital, which has a dedicated team with established expertise and broad networks across Asia, is focussed on the strategy of creating income and capital growth for shareholders. Harmony Capital is sourcing predominately private opportunities and continues to create a strong pipeline of income generating assets from potential investments in growth sectors across Asia including healthcare, fintech, hospitality, IT and property.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABVLLFKKFEBBK
Date   Source Headline
17th Mar 201511:00 amRNSWarrant Exercise Price - Correction
10th Mar 20153:02 pmRNSIssue of Equity
2nd Mar 20157:00 amRNSAdamas Named Best Asia Pacific Lender
18th Dec 20149:28 amRNSDisposal Of Interest In Global Pharm Holdings
29th Oct 20147:00 amRNSADAMAS Wins AICFC PE Credit Fund Of The Year Award
23rd Oct 20147:00 amRNSBRJ Fund exits Project Innovation
8th Oct 20147:00 amRNSGreater China Credit Fund
29th Sep 20147:00 amRNSKey Adviser Appointments by Investment Manager
24th Sep 20147:00 amRNSHalf Yearly Report
14th Aug 20147:00 amRNSBRJ Fund Exit and New Investments
6th Aug 20141:31 pmRNSAIM Disclosure Update
18th Jul 20147:00 amRNSAppointment of Joint Broker
14th Jul 20143:55 pmRNSResult of AGM
10th Jul 201411:48 amRNSUpdate to Issue of Equity
4th Jul 20147:00 amRNSFurther Investment in BRJ China Credit Fund
27th Jun 20147:00 amRNSChina's Cross-Border Funding Reforms
19th Jun 20142:02 pmRNSOffer to Warrantholders, Share Consolidation etc
17th Jun 201410:26 amRNSLoan to Portfolio Company
6th Jun 20147:00 amRNSFinal Results
30th May 201411:48 amRNSIssue of Equity
28th May 20147:00 amRNSExit by BRJ China Credit Fund Limited
20th May 20141:31 pmRNSAdamas Wins Three ACQ Global Awards
14th May 20147:00 amRNSChange of Adviser
29th Apr 20147:00 amRNSBRJ China Credit Fund Exit
9th Apr 20147:00 amRNSInvestment in BRJ China Credit Fund Limited
1st Apr 20147:00 amRNSDividend Distribution by Greater China Credit Fund
17th Mar 20147:00 amRNSPrivate Debt Investor Awards
24th Feb 20144:40 pmRNSSecond Price Monitoring Extn
24th Feb 20144:35 pmRNSPrice Monitoring Extension
21st Feb 20144:40 pmRNSSecond Price Monitoring Extn
21st Feb 20144:35 pmRNSPrice Monitoring Extension
20th Feb 20143:21 pmRNSChanges of Name, TIDM and ISIN
18th Feb 20145:14 pmRNSCompletion of Registration and Admission
18th Feb 20149:55 amRNSResult of General Meeting
5th Feb 20149:59 amRNSSch 1-China Private Equity Investment Holdings Ltd
30th Jan 20143:58 pmRNSIrrevocable Undertaking
30th Jan 20147:30 amRNSRestoration - China Private Equity Inv Hldgs Ltd
30th Jan 20147:00 amRNSPosting of Admission Document
31st Dec 20137:30 amRNSSuspension - China Private Equity Inv Hldgs Ltd
31st Dec 20137:00 amRNSAcquisition/Statement Re. Suspension
24th Dec 20137:00 amRNSChange of Adviser
26th Nov 20134:48 pmRNSPatimas Update
20th Nov 201310:08 amRNSDirectorate Change
4th Nov 201311:16 amRNSFurther re disposal
1st Nov 201310:33 amRNSBoard Appointment
24th Sep 201312:22 pmRNSHalf Yearly Report
23rd Sep 201311:02 amRNSInvestment in Asia Bioenergy Technologies Berhad
18th Sep 201310:00 amRNSDisposal
21st Aug 20137:00 amRNSInvestment
26th Jul 201311:01 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.